Tumor-induced Osteomalacia

• CLINICAL_TRIALS trial_result · 2025-04-30
  Clinical Trial Update: Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia [Phase 1, Phase 2]

  This phase 1/2 trial evaluates gallium-68 DOTATATE PET imaging to localize phosphaturic mesenchymal tumors causing tumor-induced osteomalaci…

• CLINICAL_TRIALS trial_result · 2024-07-09
  Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO [Phase 4]

  Phase 4 clinical trial updating the safety, pharmacokinetics and efficacy of KRN23 in adult Chinese patients with tumor-induced osteomalacia…

• CLINICAL_TRIALS trial_result · 2022-09-06
  Clinical Trial Update: A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome [Phase 2]

  Phase 2 clinical trial update for KRN23 in subjects with tumor-induced osteomalacia or epidermal nevus syndrome has been completed.

• CLINICAL_TRIALS trial_result · 2021-04-08
  Clinical Trial Update: BGJ398 for the Treatment of Tumor-Induced Osteomalacia [Phase 2]

  Phase 2 trial of BGJ398 for tumor-induced osteomalacia was terminated; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2020-07-30
  Clinical Trial Update: Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS) [Phase 2]

  Phase 2 study of burosumab (KRN23) in adults with tumor-induced osteomalacia or epidermal nevus syndrome has completed, with results posted …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-07-02
  Clinical Trial Update: Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia

  This record notes a completed clinical trial investigating catheter-based localization of mesenchymal tumors in patients with tumor-induced …